MYH14 and hypertrophic cardiomyopathy: Our results also suggests a novel approach to the development of myosin‐targeted small molecules that modulate the contractility of cardiac muscle, either positively, to enhance the performance of the failing heart, or negatively, as might be useful in the treatment of diastolic failure associated with hypertrophic cardiomyopathy.